SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to recent revenue growth and speculation around a potential crypto treasury strategy, sparking significant after-hours volatility. The community is actively debating the stock's low float and potential for a short squeeze, with some cautioning against chasing the spike. Discussions also include the company's compliance status and potential catalysts for further upward movement.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the community discusses potential catalysts stemming from activity surrounding the White House's social media, drawing comparisons to the stock's previous surges. Community members are debating the potential impact of this activity and its implications for a possible short squeeze. The stock's movement is also being compared to other meme stocks like BYND, with some suggesting a rotation of interest.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors anticipate upcoming earnings and potential catalysts like rate cuts and S&P 500 inclusion. The community is closely watching for a breakout above the $30 resistance level, with many expecting a significant move post-earnings. Bullish sentiment is fueled by strong growth metrics and the company's position as a disruptor in the fintech sector.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending amid rumors of a potential acquisition by Novartis ($NVS), sending the stock soaring. The community speculates on the deal's likelihood and potential value, while noting positive clinical data and a strengthened pipeline. Discussions also involve the impact on the broader RNA therapeutics sector and comparisons to other companies in the space.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is trending following news of a $5 million production order, signaling a move from R&D to commercialization and revenue generation, a key milestone for the company. Community members are discussing the potential for further purchase orders and partnerships, particularly highlighting the connection to Luxshare and Meta, and expecting substantial growth in the AI infrastructure market. While some express concerns about market volatility and dilution, the overall sentiment remains optimistic about POET's long-term prospects in the photonics space.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending as investors react to news of Larvotto Resources rejecting its acquisition offer, with community discussions focusing on the deal's potential restructuring and the company's intrinsic value. Despite the setback, many express confidence in UAMY's fundamentals, citing existing contracts and potential government support amid increasing geopolitical tensions around critical mineral supply chains. The community is weighing the short-term bearish sentiment against the long-term potential of UAMY in the antimony market.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is trending due to the FDA's correction confirming VOQUEZNA's market exclusivity through 2032, driving optimism about the drug's long-term potential. The community is also discussing the upcoming earnings report and potential for a short squeeze, given the high short interest. Bullish sentiment is fueled by strong analyst ratings and the drug's superior profile compared to existing GERD treatments.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid discussions about potential trade deals with China and the ongoing government shutdown, with some questioning the timing of events. Community members are debating the implications of these factors on the stock and the broader market, while some highlight Trump's crypto holdings. Political commentary and comparisons to historical figures are also prevalent in the conversation.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is trending as the community discusses recent price movements and potential trading strategies, particularly around key support levels and upcoming earnings. Bullish sentiment is emerging, with some anticipating a rise toward previous highs, while others focus on the stock's defensive qualities amid market uncertainty. Discussions include long-term holds, dividend payouts, and potential spin-offs to unlock shareholder value.

ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

ETHZilla Corporation

ETHZilla Corporation is trending as investors discuss its potential undervaluation due to significant ETH holdings and cash reserves, with some highlighting Peter Thiel's investment as a bullish signal. Community members are actively debating its relation to the price of ETH and the possible influence of meme stock trends on its future performance, while others express concern about potential dilution from convertible notes.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PROF Outstanding article that hits the mark on PROF&#39;s current state. So if you want to refresh your PROF insights or learn about PROF from scratch, this is a must read. https://beyondspx.com/quote/PROF/analysis/profound-medical-s-precision-ablation-ignites-mainstream-prostate-care-expansion-nasdaq-prof

OnTheBalance

Erik Wright

Profound Medical Corp. (NASDAQ:PROF) is at an inflection point, leveraging its differentiated MR-guided TULSA-PRO ablation technology to offer superior patient outcomes and broad applicability across ...

BeyondSPX

Profound Medical's Precision Ablation Ignites Mainstream Prostate Care Expansion (NASDAQ:PROF) - PROF Stock Analysis

StockTwits Web

Profound Medical Corp

 Outstanding article that hits the mark on PROF's current state. So if you want to refresh your PROF insights or learn about PROF from scratch, this is a must read. 

Mike

It&#39;s an AI-generated booster job. With that acknowledged, yes it&#39;s a good read. As an AI-generated booster job, it also contains gross errors. I spotted two in the most cursory skimread: 
1. Aggressively expanding its sales force from from 13-15 up to 40 already happened, failed before it even reached 30, and was walked back to the starting 13-15.  Many of the layoffs were issued on July 1, couple days before the holiday.  
2. &quot;TULSA-AI Volume Reduction for BPH&quot; does NOT increase the TAM from 200,000 to 600,000. The TAM was already 600,000 the day Tulsa was FDA cleared in 2019. From 2019-2025, the majority of Tulsa-PRO customers simply elected to use their device to treat cancer. Why? You&#39;d have to ask them. So &quot;TULSA-AI Volume Reduction for BPH&quot; is nothing more than a marketing campaign to boost usage for BPH, since it wasn&#39;t happening organically.  No shame in that of course, every company should market as they see fit. But I&#39;m surprised the AI didn&#39;t pick up on it, it&#39;s simple fact.

Sam Holloman

It's an AI-generated booster job. With that acknowledged, yes it's a good read. As an AI-generated booster job, it also contains gross errors. I spotted two in the most cursory skimread: 
1. Aggressively expanding its sales force from from 13-15 up to 40 already happened, failed before it even reached 30, and was walked back to the starting 13-15.  Many of the layoffs were issued on July 1, couple days before the holiday.  
2. "TULSA-AI Volume Reduction for BPH" does NOT increase the TAM from 200,000 to 600,000. The TAM was already 600,000 the day Tulsa was FDA cleared in 2019. From 2019-2025, the majority of Tulsa-PRO customers simply elected to use their device to treat cancer. Why? You'd have to ask them. So "TULSA-AI Volume Reduction for BPH" is nothing more than a marketing campaign to boost usage for BPH, since it wasn't happening organically.  No shame in that of course, every company should market as they see fit. But I'm surprised the AI didn't pick up on it, it's simple fact.

John Tarlick

Oh wait, here&#39;s an AI gem: &quot;the Automated Contouring Assistant has reduced procedure time by several minutes, enhancing urologist confidence.&quot; 
The amount of time saved by Automated Contouring Assistant has been stated by $PROF in various ways about half a dozen times by now, but never in the same way twice. The range of time saved has been stated to be anywhere from &quot;several minutes&quot; (Q2/24 analyst call) up to &quot;45 minutes to an hour&quot; (DeviceTalks podcast June 7, 2024). In between these two extremes are 3 or 4 more. AI has unwittingly zeroed in on the minimum value!

Oh wait, here's an AI gem: "the Automated Contouring Assistant has reduced procedure time by several minutes, enhancing urologist confidence." 
The amount of time saved by Automated Contouring Assistant has been stated by 

 in various ways about half a dozen times by now, but never in the same way twice. The range of time saved has been stated to be anywhere from "several minutes" (Q2/24 analyst call) up to "45 minutes to an hour" (DeviceTalks podcast June 7, 2024). In between these two extremes are 3 or 4 more. AI has unwittingly zeroed in on the minimum value!